Sriharsha Tella to Prognosis
This is a "connection" page, showing publications Sriharsha Tella has written about Prognosis.
Connection Strength
0.462
-
Second-line therapies in advanced biliary tract cancers. Lancet Oncol. 2020 01; 21(1):e29-e41.
Score: 0.116
-
Survival and prognostic factors in patients with pancreatic squamous cell carcinoma. Eur J Surg Oncol. 2019 Sep; 45(9):1700-1705.
Score: 0.111
-
Predictors of Survival in Adrenocortical Carcinoma: An Analysis From the National Cancer Database. J Clin Endocrinol Metab. 2018 09 01; 103(9):3566-3573.
Score: 0.105
-
Association Between Treatment Facility Volume, Therapy Types, and Overall Survival in Patients With Stage IIIA Non-Small Cell Lung Cancer. J Natl Compr Canc Netw. 2019 03 01; 17(3):229-236.
Score: 0.027
-
Predictors of survival, treatment patterns, and outcomes in histiocytic sarcoma. Leuk Lymphoma. 2019 02; 60(2):553-555.
Score: 0.026
-
T cell/histiocyte-rich large B cell lymphoma: incidence, demographic disparities, and long-term outcomes. Br J Haematol. 2019 04; 185(1):140-142.
Score: 0.026
-
Natural Killer/T-cell Neoplasms: Analysis of Incidence, Patient Characteristics, and Survival Outcomes in the United States. Clin Lymphoma Myeloma Leuk. 2018 07; 18(7):475-479.
Score: 0.026
-
A prognostic scoring model for survival after locoregional therapy in de novo stage IV breast cancer. Breast Cancer Res Treat. 2018 Aug; 170(3):677-685.
Score: 0.026